Accendra Health, Inc. Cost of Revenue
Accendra Health, Inc. (ACH) reported Cost of Revenue of $349.83 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Cost of Sales
us-gaap:CostOfRevenue · last filed 2026-08-10
- Accendra Health, Inc. cost of revenue for the quarter ending 2026-06-30 was $349.83M, a 2.10% decline year-over-year.
- Accendra Health, Inc. cost of revenue for the quarter ending 2026-03-31 was $349.75M, a 1.38% decline year-over-year.
- Accendra Health, Inc. cost of revenue for the quarter ending 2025-12-31 was $385.71M, a 6.54% increase year-over-year.
- Accendra Health, Inc. cost of revenue for the quarter ending 2025-09-30 was $375.07M, a 5.63% increase year-over-year.
- Accendra Health, Inc. cost of revenue for fiscal 2025 was $1.47B, a 5.22% increase from fiscal 2024.
- Accendra Health, Inc. cost of revenue for fiscal 2024 was $1.40B, a 4.81% increase from fiscal 2023.
- Accendra Health, Inc. cost of revenue for fiscal 2023 was $1.34B, a 83.57% decline from fiscal 2022.
- Accendra Health, Inc. cost of revenue for fiscal 2022 was $8.13B, a 1.73% decline from fiscal 2021.
| Period end | Cost of Revenue 3 month | Cost of Revenue 3 month as first filed | Cost of Revenue 6 month | Cost of Revenue 6 month as first filed | Cost of Revenue 9 month | Cost of Revenue 9 month as first filed | Cost of Revenue 12 month | Cost of Revenue 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $349.83M 10-Q · filed 2026-08-10 | $699.58M 10-Q · filed 2026-08-10 | $1.09B derived: sum of 3 quarters · filed 2026-08-10 | $1.46B derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2026-03-31 | $349.75M 10-Q · filed 2026-05-11 | $735.46M derived: sum of 2 quarters · filed 2026-05-11 | $1.11B derived: sum of 3 quarters · filed 2026-05-11 | $1.47B derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-12-31 | $385.71M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $760.78M derived: sum of 2 quarters · filed 2026-02-20 | $1.12B derived: sum of 3 quarters · filed 2026-08-10 | $1.47B 10-K · filed 2026-02-20 | ||||
| 2025-09-30 | $375.07M 10-Q · filed 2025-10-31 | $732.38M derived: sum of 2 quarters · filed 2026-08-10 | $1.09B 10-Q · filed 2025-10-31 | $1.45B derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-06-30 | $357.31M 10-Q · filed 2026-08-10 | $711.96M 10-Q · filed 2026-08-10 | $1.07B derived: sum of 3 quarters · filed 2026-08-10 | $1.43B derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-03-31 | $354.64M 10-Q · filed 2026-05-11 | $2.11B 10-Q · filed 2025-05-08 | $716.67M derived: sum of 2 quarters · filed 2026-05-11 | $1.07B derived: sum of 3 quarters · filed 2026-05-11 | $1.42B derived: sum of 4 quarters · filed 2026-05-11 | |||
| 2024-12-31 | $362.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $717.11M derived: sum of 2 quarters · filed 2026-02-20 | $1.06B derived: sum of 3 quarters · filed 2026-02-20 | $1.40B 10-K · filed 2026-02-20 | $8.48B 10-K · filed 2025-02-28 | |||
| 2024-09-30 | $355.07M 10-Q · filed 2025-10-31 | $2.16B 10-Q · filed 2024-11-04 | $699.45M derived: sum of 2 quarters · filed 2025-10-31 | $1.04B 10-Q · filed 2025-10-31 | $6.37B 10-Q · filed 2024-11-04 | -$2.01B derived: sum of 4 quarters · filed 2026-02-20 | ||
| 2024-06-30 | $344.37M 10-Q · filed 2025-08-11 | $2.13B 10-Q · filed 2024-08-02 | $682.62M 10-Q · filed 2025-08-11 | $4.20B 10-Q · filed 2024-08-02 | -$2.37B derived: sum of 3 quarters · filed 2026-02-20 | -$312.26M derived: sum of 4 quarters · filed 2026-02-20 | ||
| 2024-03-31 | $2.08B 10-Q · filed 2025-05-08 | -$2.71B derived: sum of 2 quarters · filed 2026-02-20 | -$656.63M derived: sum of 3 quarters · filed 2026-02-20 | $1.39B derived: sum of 4 quarters · filed 2026-02-20 | ||||
| 2023-12-31 | -$4.79B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | -$2.73B derived: sum of 2 quarters · filed 2026-02-20 | -$689.99M derived: sum of 3 quarters · filed 2026-02-20 | $1.34B 10-K · filed 2026-02-20 | $8.21B 10-K · filed 2024-02-20 | |||
| 2023-09-30 | $2.05B 10-Q · filed 2024-11-04 | $4.10B derived: sum of 2 quarters · filed 2024-11-04 | $6.12B 10-Q · filed 2024-11-04 | $8.27B derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-06-30 | $2.04B 10-Q · filed 2024-08-02 | $4.07B 10-Q · filed 2024-08-02 | $6.21B derived: sum of 3 quarters · filed 2025-02-28 | $8.20B derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-03-31 | $2.03B 10-Q · filed 2024-05-03 | $4.17B derived: sum of 2 quarters · filed 2025-02-28 | $6.15B derived: sum of 3 quarters · filed 2025-02-28 | $8.12B derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2022-12-31 | $2.14B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $4.13B derived: sum of 2 quarters · filed 2025-02-28 | $6.10B derived: sum of 3 quarters · filed 2025-02-28 | $8.13B 10-K · filed 2025-02-28 | ||||
| 2022-09-30 | $1.98B 10-Q · filed 2023-11-03 | $3.95B derived: sum of 2 quarters · filed 2023-11-03 | $5.99B 10-Q · filed 2023-11-03 | $8.11B derived: sum of 4 quarters · filed 2024-02-20 | ||||
| 2022-06-30 | $1.97B 10-Q · filed 2023-08-04 | $4.00B 10-Q · filed 2023-08-04 | $6.13B derived: sum of 3 quarters · filed 2024-02-20 | $8.30B derived: sum of 4 quarters · filed 2024-02-20 | ||||
| 2022-03-31 | $2.03B 10-Q · filed 2023-05-05 | $4.16B derived: sum of 2 quarters · filed 2024-02-20 | $6.33B derived: sum of 3 quarters · filed 2024-02-20 | $8.42B derived: sum of 4 quarters · filed 2024-02-20 | ||||
| 2021-12-31 | $2.13B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $4.30B derived: sum of 2 quarters · filed 2024-02-20 | $6.39B derived: sum of 3 quarters · filed 2024-02-20 | $8.27B 10-K · filed 2024-02-20 | ||||
| 2021-09-30 | $2.17B 10-Q · filed 2022-11-02 | $4.26B derived: sum of 2 quarters · filed 2022-11-02 | $6.15B 10-Q · filed 2022-11-02 | $8.11B derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-06-30 | $2.09B 10-Q · filed 2022-08-03 | $3.97B 10-Q · filed 2022-08-03 | $5.94B derived: sum of 3 quarters · filed 2023-02-28 | $7.78B derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-03-31 | $1.88B 10-Q · filed 2022-05-04 | $3.85B derived: sum of 2 quarters · filed 2023-02-28 | $5.69B derived: sum of 3 quarters · filed 2023-02-28 | $7.23B derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2020-12-31 | $1.96B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $3.81B derived: sum of 2 quarters · filed 2023-02-28 | $5.35B derived: sum of 3 quarters · filed 2023-02-28 | $7.20B 10-K · filed 2023-02-28 | ||||
| 2020-09-30 | $1.84B 10-Q · filed 2021-11-03 | $3.38B derived: sum of 2 quarters · filed 2021-11-03 | $5.24B 10-Q · filed 2021-11-03 | $7.14B derived: sum of 4 quarters · filed 2022-02-23 | ||||
| 2020-06-30 | $1.54B 10-Q · filed 2021-08-03 | $3.39B 10-Q · filed 2021-08-03 | $5.30B derived: sum of 3 quarters · filed 2022-02-23 | $7.31B derived: sum of 4 quarters · filed 2022-02-23 | ||||
| 2020-03-31 | $1.85B 10-Q · filed 2021-05-05 | $3.76B derived: sum of 2 quarters · filed 2022-02-23 | $5.77B derived: sum of 3 quarters · filed 2022-02-23 | $7.86B derived: sum of 4 quarters · filed 2022-02-23 | ||||
| 2019-12-31 | $1.91B derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $3.92B derived: sum of 2 quarters · filed 2022-02-23 | $6.01B derived: sum of 3 quarters · filed 2022-02-23 | $8.08B 10-K · filed 2022-02-23 | ||||
| 2019-09-30 | $2.01B 10-Q · filed 2020-11-03 | $2.04B 10-Q · filed 2019-11-06 | $4.10B derived: sum of 2 quarters · filed 2020-11-03 | $6.18B 10-Q · filed 2020-11-03 | $6.26B 10-Q · filed 2019-11-06 | $8.23B derived: sum of 4 quarters · filed 2020-11-03 | ||
| 2019-06-30 | $2.09B 10-Q · filed 2020-08-05 | $2.12B 10-Q · filed 2019-08-07 | $4.16B 10-Q · filed 2020-08-05 | $4.22B 10-Q · filed 2019-08-07 | $6.22B derived: sum of 3 quarters · filed 2020-08-05 | $8.33B derived: sum of 4 quarters · filed 2020-08-05 | ||
| 2019-03-31 | $2.07B 10-Q · filed 2020-05-06 | $2.10B 10-Q · filed 2019-05-07 | $4.13B derived: sum of 2 quarters · filed 2020-05-06 | $6.24B derived: sum of 3 quarters · filed 2020-05-06 | $8.37B derived: sum of 4 quarters · filed 2020-05-06 | |||
| 2018-12-31 | $2.05B derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-04 | $4.17B derived: sum of 2 quarters · filed 2020-03-04 | $6.30B derived: sum of 3 quarters · filed 2020-03-04 | $8.35B 10-K · filed 2020-03-04 | $8.47B 10-K · filed 2019-03-06 | |||
| 2018-09-30 | $2.11B 10-Q · filed 2019-11-06 | $4.25B derived: sum of 2 quarters · filed 2019-11-06 | $6.29B 10-Q · filed 2019-11-06 | $8.37B derived: sum of 4 quarters · filed 2019-11-06 | ||||
| 2018-06-30 | $2.13B 10-Q · filed 2019-08-07 | $4.18B 10-Q · filed 2019-08-07 | $6.26B derived: sum of 3 quarters · filed 2019-08-07 | $8.29B derived: sum of 4 quarters · filed 2019-08-07 | ||||
| 2018-03-31 | $2.05B 10-Q · filed 2019-05-07 | $4.12B derived: sum of 2 quarters · filed 2019-05-07 | $6.15B derived: sum of 3 quarters · filed 2019-05-07 | |||||
| 2017-12-31 | $2.07B derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $4.11B derived: sum of 2 quarters · filed 2019-03-06 | $8.15B 10-K · filed 2019-03-06 | |||||
| 2017-09-30 | $2.03B 10-Q · filed 2018-11-05 | $6.07B 10-Q · filed 2018-11-05 | ||||||
| 2016-12-31 | $8.54B 10-K · filed 2019-03-06 | |||||||
| 2010-09-30 | $1.87B 10-Q · filed 2010-10-29 | $3.69B derived: sum of 2 quarters · filed 2010-10-29 | $5.47B 10-Q · filed 2010-10-29 | |||||
| 2010-06-30 | $1.83B 10-Q · filed 2010-07-30 | $3.61B 10-Q · filed 2010-07-30 | ||||||
| 2009-09-30 | $1.83B 10-Q · filed 2010-10-29 | $3.65B derived: sum of 2 quarters · filed 2010-10-29 | $5.41B 10-Q · filed 2010-10-29 | |||||
| 2009-06-30 | $1.82B 10-Q · filed 2010-07-30 | $3.58B 10-Q · filed 2010-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HENRY SCHEIN INC (HSIC) | United States | $9.536B | 23.59 |